HomeNDC LookupRxCUI directory › RxCUI 831246

Cromolyn sodium 10 MG/ML Inhalation Solution — RxCUI 831246

RxNorm drug concept · Semantic clinical drug
RxCUI 831246 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI831246
Official nameCromolyn sodium 10 MG/ML Inhalation Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascromolyn sodium 20 MG per 2 ML Inhalation Solution; cromolyn sodium 20 MG in 2 ML Inhalation Solution
FDA products mapped3
Package NDCs mapped4
Reported Medicaid activity (SDUD)754 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cromolyn Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No — and this is really important to understand. Cromolyn sodium is a preventive medicine only. It does not open your airways once they've tightened up. You should always have a se...
  • Will this inhaler stop an asthma attack if I'm already having one?
  • It can take several weeks of regular use before you feel the full benefit — though some people notice improvement sooner. The key is consistency. Taking it at the same times every...
  • How long does it take before I notice it working?
📖 Read our full Cromolyn Oral Inhalation guide →

🕸️ Concept Web — How Cromolyn sodium 10 MG/ML Inhalation Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cromolyn sodium 10 MG/ML Inhalation Solution RxCUI 831246

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cromolyn 42612
    • Cromolyn sodium 3538
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cromolyn Inhalation Solution 2108316
    • Cromolyn sodium Inhalation Solution 2649052
    • Cromolyn Inhalant Product 1155844
    • Cromolyn sodium Inhalant Product 2659367
    • Inhalation Solution 346161
    • Inhalant Product 1151123
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cromolyn sodium 10 MG/ML 831245

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cromolyn sodium 10 MG/ML SCDC · 831245
  • Cromolyn Inhalation Solution SCDF · 2108316
  • Cromolyn sodium Inhalation Solution SCDFP · 2649052
  • Cromolyn Inhalant Product SCDG · 1155844
  • Cromolyn sodium Inhalant Product SCDGP · 2659367

📦 FDA Products & Package NDCs

3 products · 4 package NDCs
4 package NDCs map to RxCUI 831246 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00172-6406-49 12 POUCH in 1 CARTON (0172-6406-49) / 5 VIAL, SINGLE-DOSE i... Cromolyn Sodium Teva Pharmaceuticals USA, Inc. 2000-01-18
42571-0350-09 5 CARTON in 1 CARTON (42571-350-09) / 12 AMPULE in 1 CARTON... Cromolyn Sodium Micro Labs Limited 2022-06-01
42571-0350-50 10 CARTON in 1 CARTON (42571-350-50) / 12 AMPULE in 1 CARTO... Cromolyn Sodium Micro Labs Limited 2022-06-01
76204-0028-60 2 POUCH in 1 CARTON (76204-028-60) / 30 AMPULE in 1 POUCH (... Cromolyn Sodium Inhalation Solution Ritedose Pharmaceuticals, LLC 2021-12-01
Observed labelers: Micro Labs Limited (2) · Ritedose Pharmaceuticals, LLC (1) · Teva Pharmaceuticals USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7631 Cromolyn sodium noncomp unit 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.